Logo image of AYRO

AYRO INC (AYRO) Stock Fundamental Analysis

NASDAQ:AYRO - Nasdaq - US0547482077 - Common Stock - Currency: USD

7.5624  -0.08 (-1%)

After market: 7.52 -0.04 (-0.56%)

Fundamental Rating

2

AYRO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 37 industry peers in the Automobiles industry. AYRO has a great financial health rating, but its profitability evaluates not so good. AYRO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AYRO has reported negative net income.
In the past year AYRO has reported a negative cash flow from operations.
AYRO had negative earnings in each of the past 5 years.
In the past 5 years AYRO always reported negative operating cash flow.
AYRO Yearly Net Income VS EBIT VS OCF VS FCFAYRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -49.76%, AYRO is not doing good in the industry: 67.57% of the companies in the same industry are doing better.
With a Return On Equity value of -81.46%, AYRO perfoms like the industry average, outperforming 45.95% of the companies in the same industry.
Industry RankSector Rank
ROA -49.76%
ROE -81.46%
ROIC N/A
ROA(3y)-52.62%
ROA(5y)-99.5%
ROE(3y)-81.06%
ROE(5y)-2540.04%
ROIC(3y)N/A
ROIC(5y)N/A
AYRO Yearly ROA, ROE, ROICAYRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5K -10K

1.3 Margins

AYRO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AYRO Yearly Profit, Operating, Gross MarginsAYRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K

More info and screens

7

2. Health

2.1 Basic Checks

AYRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AYRO has more shares outstanding
The number of shares outstanding for AYRO has been increased compared to 5 years ago.
AYRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AYRO Yearly Shares OutstandingAYRO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
AYRO Yearly Total Debt VS Total AssetsAYRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

AYRO has an Altman-Z score of -2.36. This is a bad value and indicates that AYRO is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.36, AYRO is not doing good in the industry: 62.16% of the companies in the same industry are doing better.
There is no outstanding debt for AYRO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.36
ROIC/WACCN/A
WACC8.9%
AYRO Yearly LT Debt VS Equity VS FCFAYRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 6.55 indicates that AYRO has no problem at all paying its short term obligations.
AYRO's Current ratio of 6.55 is amongst the best of the industry. AYRO outperforms 100.00% of its industry peers.
AYRO has a Quick Ratio of 5.92. This indicates that AYRO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 5.92, AYRO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.55
Quick Ratio 5.92
AYRO Yearly Current Assets VS Current LiabilitesAYRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

AYRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.91%, which is quite impressive.
AYRO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -76.66%.
AYRO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -32.19% yearly.
EPS 1Y (TTM)39.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.73%
Revenue 1Y (TTM)-76.66%
Revenue growth 3Y-32.19%
Revenue growth 5YN/A
Sales Q2Q%-93.89%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y21.8%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1968.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AYRO Yearly Revenue VS EstimatesAYRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
AYRO Yearly EPS VS EstimatesAYRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 -2 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AYRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AYRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AYRO Price Earnings VS Forward Price EarningsAYRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AYRO Per share dataAYRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AYRO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AYRO INC

NASDAQ:AYRO (6/27/2025, 8:00:00 PM)

After market: 7.52 -0.04 (-0.56%)

7.5624

-0.08 (-1%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)05-14 2025-05-14
Earnings (Next)08-13 2025-08-13
Inst Owners4.44%
Inst Owner Change-26.16%
Ins Owners2.1%
Ins Owner Change0%
Market Cap64.58M
Analysts82.86
Price TargetN/A
Short Float %8.74%
Short Ratio2.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-99.92%
Min Revenue beat(2)-100%
Max Revenue beat(2)-99.83%
Revenue beat(4)0
Avg Revenue beat(4)-83.67%
Min Revenue beat(4)-100%
Max Revenue beat(4)-39.53%
Revenue beat(8)1
Avg Revenue beat(8)-53.68%
Revenue beat(12)3
Avg Revenue beat(12)-40.04%
Revenue beat(16)4
Avg Revenue beat(16)-41.93%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 291.31
P/FCF N/A
P/OCF N/A
P/B 2.94
P/tB 2.94
EV/EBITDA N/A
EPS(TTM)-4.13
EYN/A
EPS(NY)-5.42
Fwd EYN/A
FCF(TTM)-1.81
FCFYN/A
OCF(TTM)-1.78
OCFYN/A
SpS0.03
BVpS2.57
TBVpS2.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -49.76%
ROE -81.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.62%
ROA(5y)-99.5%
ROE(3y)-81.06%
ROE(5y)-2540.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.4%
Cap/Sales 106.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.55
Quick Ratio 5.92
Altman-Z -2.36
F-Score4
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)168.75%
Cap/Depr(5y)138.53%
Cap/Sales(3y)171.63%
Cap/Sales(5y)120.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.73%
EPS Next Y21.8%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-76.66%
Revenue growth 3Y-32.19%
Revenue growth 5YN/A
Sales Q2Q%-93.89%
Revenue Next Year1968.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-0.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.09%
OCF growth 3YN/A
OCF growth 5YN/A